The Sherwin-Williams Company (SHW) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 21/100
- 10Y CAGR
- 7.6%
- Median YoY
- 5.4%
- YoY volatility
- σ 11.3pp· uneven
- Quarters ≥ 20%
- 4 of 40
- Negative quarters
- 3
- Valuation vs own 10Y history
- P/S 3.6x · 10Y median 3.1x · 71st percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 4 of 40 → 4 of 40 pts
- Steadiness (typical swing 11.3pp) → 16.9 of 25 pts
- Pace (median 5.4% YoY) → 0 of 20 pts
- Latest quarter (7.5% YoY) → 0 of 15 pts
- Score: 21 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 7.6% | 5.4% | 11.3pp | 4 of 40 | 3 |
| EPSEPS | 10.7% | 11.9% | 61.5pp | 15 of 40 | 9 |
| Op cash flowOperating cash flow | 9.1% | 21.1% | 80.6pp | 18 of 35 | 14 |
| EBITDAEBITDA | 9.3% | 8.9% | 20.9pp | 11 of 40 | 6 |
| FCFFree cash flow | 8.1% | 30% | 97.8pp | 17 of 31 | 12 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: SHW on the compounders surface · All compounders, ranked